{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:08:08Z","timestamp":1759057688710},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":5183,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[1991,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Derivatives of Sabin 3 shed from recipients of oral poliovirus vaccine in the United States (U.S.) were examined for genetic changes identified in strains excreted by vaccinees in the United Kingdom [U.K.; Evans et al., 1985; Cammack et al., 1988, Macadam et al., 1989]. Among the eight primary vaccinees studied, the duration of excretion and molecular evolution of type 3 strains varied greatly. The period of virus excretion after vaccination ranged from as few as 2 days to as many as 36 days. Nucleotide sequence analysis of viral RNAs extracted from shed virus indicated that only fifty percent of the vaccinees exclusively excreted strains in which the attenuating mutation at nucleotide 472 in the 5' noncoding region of the genome had reverted from uracil (U) to cytosine (C), the nucleotide found in neurovirulent strains. Compared to the wild\u2010type Leon strain, the low activity of stool isolate KW4 in a complete monkey neurovirulence test demonstrated that presence of C at 472 does not render a type 3 strain pathogenic. Conversely, anisolate was identified which efficiently replicated in monkey nervous tissue and maintained the attenuated U at 472. Oligonucleotide fingerprinting and sequence analysis of viral RNAs from stool isolates indicated that one vaccinee (KW) eventually excreted intertypic recombinant strains consistent with those reported in the U.K. studies. Unique to this study, one vaccinee (KS) excreted nonrecombinant virus possessing U at 472 for up to 21 days. The significance of the KS strain profile in relation to differences in the U.S. vaccine compared to the vaccine distributed in the U.K. and other countries is discussed.<\/jats:p>","DOI":"10.1002\/jmv.1890350206","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T20:22:01Z","timestamp":1172866921000},"page":"101-109","source":"Crossref","is-referenced-by-count":21,"title":["Oral poliovirus vaccine in the United States: Molecular characterization of sabin type 3 after replication in the gut of vaccinees"],"prefix":"10.1002","volume":"35","author":[{"given":"Joanne M.","family":"Tatem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Weeks\u2010Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Mento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Dimichele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Georgiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willard F.","family":"Waterfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Sheip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Costalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis R.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(83)80031-6"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(79)80042-6"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(88)90113-4"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/12.20.7787"},{"key":"e_1_2_1_6_1","unstructured":"Centers for Disease Control(1986): Poliomyelitis\u2010United States 1975\u20131984. Morbidity and Mortality Weekly Report 35:180\u2013182."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(86)90626-3"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890320205"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/314548a0"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890240102"},{"key":"e_1_2_1_11_1","first-page":"357","volume-title":"Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenecity","author":"Kew OM","year":"1984"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-56-2-337"},{"key":"e_1_2_1_13_1","first-page":"41","volume-title":"Methods in Virology","author":"Kew OM","year":"1984"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.24.11705"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(89)90183-9"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1959.03010270001001"},{"key":"e_1_2_1_17_1","first-page":"384","volume-title":"Poliomyelitis. Fifth International Poliomyelitis Conference, Copenhagen","author":"Melnick JL","year":"1961"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-5-1091"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-4-693"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-5-1117"},{"key":"e_1_2_1_21_1","first-page":"1335","article-title":"Vaccine\u2010associated paralytic poliomyelitis","volume":"257","author":"Nkowane BM","year":"1987","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.99.6.551"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/11.16.5629"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(84)90084-6"},{"key":"e_1_2_1_25_1","unstructured":"Weeks\u2010LevyC TatemJM Di MicheleSJ WaterfieldW GeorgiaA MentoSJ. Submitted for publication."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.63.3.1338-1344.1989"},{"key":"e_1_2_1_27_1","unstructured":"World Health Organization Technical Report Series(1988): Requirements for Poliomyelitis vaccine (oral). (Requirements for Biological Substances No. 7) No. 771 91\u201392."}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.1890350206","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.1890350206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T01:15:35Z","timestamp":1698023735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.1890350206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["10.1002\/jmv.1890350206"],"URL":"https:\/\/doi.org\/10.1002\/jmv.1890350206","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}